Norwich, Connecticut, July 18, 2023 – AVS Bio (the “Company”), the leading provider of specific pathogen free (“SPF”) products and services that support biologic development and manufacturing, is pleased to announce the appointment of Jac Price as Chief Executive Officer.
With over 25 years of executive leadership experience in the life sciences and biomedical testing industries, Mr. Price most recently served as SVP of Supply Chain & Manufacturing at Abcam and was previously SVP of Global Operations & Diagnostics at Beckman Coulter. In joining AVS Bio, Mr. Price brings a wealth of expertise and a proven track record of success in leading companies through periods of new product development and transformative growth.
Mr. Price expressed his enthusiasm for joining AVS Bio, stating, “The AVS Bio team has built an outstanding business to support its global customer base in the development and manufacturing of biologics that are critical to both human and animal health. I am excited to work with the talented team already in place and leverage their expertise to accelerate the development of new products and services and expand into new markets across diagnostics and immunology.”
Malcolm Little, a Director at AVS Bio and a Partner at Arlington Capital Partners, said, “Jac’s addition to AVS Bio as CEO is very exciting for the Company. His exceptional leadership skills, proven acquisition and integration expertise, and extensive experience across life sciences and diagnostics make him the perfect fit to lead the expansion of the AVS Bio platform alongside our existing management team.”
Deb Tosto, President of AVS Bio, added, “We are thrilled to welcome Jac to the AVS Bio family. With his arrival, we look forward to an even greater emphasis on innovation, research and development, and strategic partnerships that will enable us to expand our offerings to meet the evolving needs of our growing pharmaceutical customer base.”